<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"><channel>
  <title>Regeneron Pharmaceuticals — fllwup^</title>
  <link>https://fllwup.co/topic/regeneron-pharmaceuticals/</link>
  <description>Track Regeneron Pharmaceuticals news in real time — S&amp;P 500 — biotechnology, REGN. fllwup^ collects the latest Regeneron Pharmaceuticals headlines from every major source into one live feed — free, no account, no algorithm.</description>
  <lastBuildDate>Sun, 22 Nov 2026 10:07:49 GMT</lastBuildDate>
  <item><title>Regeneron Pharmaceuticals, Inc. (REGN) Stock Forecasts</title><link>https://news.google.com/rss/articles/CBMiiAFBVV95cUxOWmp0WmRzNXBWRGhHcF84cXJiN3NGRUczb2JtVzJETzM1TDNxdlA5Um9NNFgwSjQ1MF80cHZpU3ZPaFFaWkNOTFgzMlpUeDFRb1k2aGx5cTVBRGlUTVJuV2RzOGdmbkVmaG96Y0JfSy1ISXNtS2RKMm5qOU9aRnBpaDM2bWoxZnJt?oc=5</link><source url="https://news.google.com/rss/articles/CBMiiAFBVV95cUxOWmp0WmRzNXBWRGhHcF84cXJiN3NGRUczb2JtVzJETzM1TDNxdlA5Um9NNFgwSjQ1MF80cHZpU3ZPaFFaWkNOTFgzMlpUeDFRb1k2aGx5cTVBRGlUTVJuV2RzOGdmbkVmaG96Y0JfSy1ISXNtS2RKMm5qOU9aRnBpaDM2bWoxZnJt?oc=5">Yahoo Finance</source></item>
  <item><title>Regeneron, Alnylam win FDA nod for myasthenia gravis therapy</title><link>https://news.google.com/rss/articles/CBMikAFBVV95cUxPNmRNVVhWaFoxUE5DMEFsR3AteGZ2QW13SVNlOGVPbk5PZm9mZEN1SEhaU014Y0p1akk0NUxra2FUMHF1QVVWaURXOElYZ1k2YjR0eHA4RmpfRXRLUDFmdTFFQWJZZ0E2ZVRlU1pRYWZJZ2EyUFlNa1V4dXgwMmpjTDZKNFJiTDdSQjZ0SnFvQkE?oc=5</link><source url="https://news.google.com/rss/articles/CBMikAFBVV95cUxPNmRNVVhWaFoxUE5DMEFsR3AteGZ2QW13SVNlOGVPbk5PZm9mZEN1SEhaU014Y0p1akk0NUxra2FUMHF1QVVWaURXOElYZ1k2YjR0eHA4RmpfRXRLUDFmdTFFQWJZZ0E2ZVRlU1pRYWZJZ2EyUFlNa1V4dXgwMmpjTDZKNFJiTDdSQjZ0SnFvQkE?oc=5">Seeking Alpha</source></item>
  <item><title>FDA Approval Could Be A Big Moment For Regeneron Stock (REGN)</title><link>https://news.google.com/rss/articles/CBMi7wFBVV95cUxOTkxDbGhWVFJDZzZDU0dtZVRvSnhXdHlCd0xyc0gtYkg2TFByMElHYTJxNDMtYUp6aVoyTExXQ0JxX1Myb19IdXdCZ0N4N29JdnFSUnpKLTZjWDRlaUhIbTFCY3VpVnlpQmk5V1prdFpDQjF1SUVDWURlaVNDWjhuUzA3TDF1cGdGWjhOdG9oaEFSbXNuVi14TFVncjRvZTAtaS1BY3cySFktaXpISHZ5Z2Fyc0VzSWpIOGh1MHE1dzQyeTRwdEV6Z1RIbE43aUdIUDRiUXZJV25qRHUtVVJmNTM4QVdHa1RpNnAwYllta9IB9AFBVV95cUxQNU9FTERJTTdBc085cmxuN0lwUmg1a0pjOWowUFlsaXRBY2s1djk5VkZDRHpUcVJzdE9tVXF2ZkR1Q1duZTdWUGF2U0xhSjhTZ0FXMGhuY1BCWHZ1SDl5R0p3Z2Q3NjVKa3pHYnhiQWVOTV9jT2VJWElrbm9GdDJydFZjMTh3WExESi1UMV9wRGo2TWlhM1l0VllrdHg1ZVpDblF0VlVOeTJLTTA1cFJUaWpFVm05cVJfVllRMjBlR056cjZZbVlYUktaVnJ5ZWpQNVVBNGJXOXdnYzU0aGxoUm5tM0taUzJPQk03RFFuZlRRSm5G?oc=5</link><source url="https://news.google.com/rss/articles/CBMi7wFBVV95cUxOTkxDbGhWVFJDZzZDU0dtZVRvSnhXdHlCd0xyc0gtYkg2TFByMElHYTJxNDMtYUp6aVoyTExXQ0JxX1Myb19IdXdCZ0N4N29JdnFSUnpKLTZjWDRlaUhIbTFCY3VpVnlpQmk5V1prdFpDQjF1SUVDWURlaVNDWjhuUzA3TDF1cGdGWjhOdG9oaEFSbXNuVi14TFVncjRvZTAtaS1BY3cySFktaXpISHZ5Z2Fyc0VzSWpIOGh1MHE1dzQyeTRwdEV6Z1RIbE43aUdIUDRiUXZJV25qRHUtVVJmNTM4QVdHa1RpNnAwYllta9IB9AFBVV95cUxQNU9FTERJTTdBc085cmxuN0lwUmg1a0pjOWowUFlsaXRBY2s1djk5VkZDRHpUcVJzdE9tVXF2ZkR1Q1duZTdWUGF2U0xhSjhTZ0FXMGhuY1BCWHZ1SDl5R0p3Z2Q3NjVKa3pHYnhiQWVOTV9jT2VJWElrbm9GdDJydFZjMTh3WExESi1UMV9wRGo2TWlhM1l0VllrdHg1ZVpDblF0VlVOeTJLTTA1cFJUaWpFVm05cVJfVllRMjBlR056cjZZbVlYUktaVnJ5ZWpQNVVBNGJXOXdnYzU0aGxoUm5tM0taUzJPQk03RFFuZlRRSm5G?oc=5">Simply Wall St</source></item>
  <item><title>Regeneron (REGN) stock trades up, here is why</title><link>https://news.google.com/rss/articles/CBMinAFBVV95cUxPNnVmWTVHY3pmcEpmM2hLczZtRnF5aTRQX3NVeDR6dXdFWkNHcGk1YnJLM19YSDEteUh2U08xeGFwU2NDTUZWTWJOeGNBOTNuQUdIM2l1WlVYWkFNR0dCQldRWUhodm9FMXBVZDViMGhBYjZwVjdzUHB2UlJfREdWSTk5VGdDQ0YtZ3I2VW5qR1ZhYV9Pc3liM2hrSnE?oc=5</link><source url="https://news.google.com/rss/articles/CBMinAFBVV95cUxPNnVmWTVHY3pmcEpmM2hLczZtRnF5aTRQX3NVeDR6dXdFWkNHcGk1YnJLM19YSDEteUh2U08xeGFwU2NDTUZWTWJOeGNBOTNuQUdIM2l1WlVYWkFNR0dCQldRWUhodm9FMXBVZDViMGhBYjZwVjdzUHB2UlJfREdWSTk5VGdDQ0YtZ3I2VW5qR1ZhYV9Pc3liM2hrSnE?oc=5">Yahoo Finance</source></item>
  <item><title>The day after exercising options on 17,000 Regeneron (REGN) shares, Andrew J. Murphy sold stock.</title><link>https://news.google.com/rss/articles/CBMiwAFBVV95cUxQOE5NYW9oTFZIVFBFaHh2cS1xYnVSUllBdVFDcWdCRFFTY1k2RUNvdUNQYzdORjVqSFZOS0wySDJ3QS1pSzJNNlktVjBRN0tCRUlEemUyRnBEYTRZX1NPR25HeDVJQjM1MzA0XzVMSlh1TFJIMmR1amhwSXlaVmRmM0d0dW9wLUdkSDRpYzhfbDFrVUp5MkpuVWRmZlk0cWNMYzEyVmxhNnVyb2hzNnpXQU9LcWFBQzlQdnZnQmlnWnE?oc=5</link><source url="https://news.google.com/rss/articles/CBMiwAFBVV95cUxQOE5NYW9oTFZIVFBFaHh2cS1xYnVSUllBdVFDcWdCRFFTY1k2RUNvdUNQYzdORjVqSFZOS0wySDJ3QS1pSzJNNlktVjBRN0tCRUlEemUyRnBEYTRZX1NPR25HeDVJQjM1MzA0XzVMSlh1TFJIMmR1amhwSXlaVmRmM0d0dW9wLUdkSDRpYzhfbDFrVUp5MkpuVWRmZlk0cWNMYzEyVmxhNnVyb2hzNnpXQU9LcWFBQzlQdnZnQmlnWnE?oc=5">Stock Titan</source></item>
  <item><title>Regeneron Pharmaceuticals, Inc. (NASDAQ:REGN) Stock Has Average Target Price of $904.41</title><link>https://news.google.com/rss/articles/CBMi3gFBVV95cUxOS3dCcHR4VF9wRmM3ejlDcHNZNVJLOGVwV3g1eU5fSFB5Q0NleERrU3lNNG5ScUZlSi0xamtfNHR5bUppUWduaWlEWHhZTjFHcWhXUDdYYmw0ZzdETFdZTzdsdDRsYUNLeERZX3IzYWhtMDU2TUxJZFBCQXIyNndkRGNrY2ZLZmZ2bHdyODdBMEpJX3ZBeWhpOHdBMDhZamxVWTZXaUVWUVd4Wk1yZFFWcnpIQUJra3gtVVVYdk5NaEgzMkQ0eWQzTzYyNGN3Sm1IVFlvZ01mNVgzVEpUSmc?oc=5</link><source url="https://news.google.com/rss/articles/CBMi3gFBVV95cUxOS3dCcHR4VF9wRmM3ejlDcHNZNVJLOGVwV3g1eU5fSFB5Q0NleERrU3lNNG5ScUZlSi0xamtfNHR5bUppUWduaWlEWHhZTjFHcWhXUDdYYmw0ZzdETFdZTzdsdDRsYUNLeERZX3IzYWhtMDU2TUxJZFBCQXIyNndkRGNrY2ZLZmZ2bHdyODdBMEpJX3ZBeWhpOHdBMDhZamxVWTZXaUVWUVd4Wk1yZFFWcnpIQUJra3gtVVVYdk5NaEgzMkQ0eWQzTzYyNGN3Sm1IVFlvZ01mNVgzVEpUSmc?oc=5">MarketBeat</source></item>
  <item><title>Does Flexible Libtayo Dosing Change The Bull Case For Regeneron Pharmaceuticals Stock?</title><link>https://news.google.com/rss/articles/CBMinAFBVV95cUxOOGdWcHFidVRuOXBtbnZ6NDhmSm1XeVUwdUNTT2Q2b0QzVmtlcHNnQW9HZU1FU0ZVN1g3eWY4V0FSN0pieV8xWVNFTGsycld1T3NjdDYwbURiVFBtY2dSdS0xU2FjdWhNeUM1TDNJazJSaU5aZ3I5SXdyNndGRHNVWGdoTGxNNzZQNUJUYnZHb09UcjY5alpYN0E4cDc?oc=5</link><source url="https://news.google.com/rss/articles/CBMinAFBVV95cUxOOGdWcHFidVRuOXBtbnZ6NDhmSm1XeVUwdUNTT2Q2b0QzVmtlcHNnQW9HZU1FU0ZVN1g3eWY4V0FSN0pieV8xWVNFTGsycld1T3NjdDYwbURiVFBtY2dSdS0xU2FjdWhNeUM1TDNJazJSaU5aZ3I5SXdyNndGRHNVWGdoTGxNNzZQNUJUYnZHb09UcjY5alpYN0E4cDc?oc=5">Yahoo Finance</source></item>
  <item><title>REGN Stock Drop: Regeneron Clinical Trials Lead to 9% Stock Drop and Securities Fraud Class Action for Investors</title><link>https://news.google.com/rss/articles/CBMi-gFBVV95cUxQQmlGRGNKMlAyZV9BeDRZMjJyY3VpUUszdmRVS25laDJaMjM2ZjE3Y3YxTFk0aTVCaWdJTEo4S040YzVDWVcwWUJsZDZOaVE4VU5Ka3k0WmZhQnNJS0hSb3M0VFVESk5sWXYxSVdJX1VkSWxOZGh4aGo2RDlsWVBRUm9tUUlvUUQzSTlwNzVnczVia2xRWElibjhUclo4WjhkSl8tX0xRVVNOMURONHRibUNwaVpONzlRNEdicl9seXphMGVPNWNucVBaOS1ORVI5LTE0TVo0NjR5dXlvRWdIdUtEbWpGTkJjek5FWTBCVGtjcERpNUpkNjV3?oc=5</link><source url="https://news.google.com/rss/articles/CBMi-gFBVV95cUxQQmlGRGNKMlAyZV9BeDRZMjJyY3VpUUszdmRVS25laDJaMjM2ZjE3Y3YxTFk0aTVCaWdJTEo4S040YzVDWVcwWUJsZDZOaVE4VU5Ka3k0WmZhQnNJS0hSb3M0VFVESk5sWXYxSVdJX1VkSWxOZGh4aGo2RDlsWVBRUm9tUUlvUUQzSTlwNzVnczVia2xRWElibjhUclo4WjhkSl8tX0xRVVNOMURONHRibUNwaVpONzlRNEdicl9seXphMGVPNWNucVBaOS1ORVI5LTE0TVo0NjR5dXlvRWdIdUtEbWpGTkJjek5FWTBCVGtjcERpNUpkNjV3?oc=5">PR Newswire</source></item>
  <item><title>Regeneron (REGN) Stock May Trade At A Discount Following Strong Q3 Earnings</title><link>https://news.google.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?oc=5</link><source url="https://news.google.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?oc=5">Simply Wall St</source></item>
  <item><title>Evaluating Bullish Potential in Regeneron Pharmaceuticals (REGN) Stock</title><link>https://news.google.com/rss/articles/CBMiuwFBVV95cUxPZ1lITzE1em0yd2liNUFPb3J5Tkx5ZHgwNmppYk5nQlE4Y2lmMGpWSlFpc054U1hfaWRGY3JyU2lmVzF6MW5BNVkyazVyUUlEU25Bek1VNDdQX1M4MWU2S1NKaEF5VnAzTWFSNUk5R3Y2VjRENHplNzQwMEdPSExqSmZrOEtwOVFmSkNCbFh2WEtBZXQ0d1J1cVVubnRmUHU2dEhqc1Z6R2RnckdHZlByLTNiYUd1MWh3cmV3?oc=5</link><source url="https://news.google.com/rss/articles/CBMiuwFBVV95cUxPZ1lITzE1em0yd2liNUFPb3J5Tkx5ZHgwNmppYk5nQlE4Y2lmMGpWSlFpc054U1hfaWRGY3JyU2lmVzF6MW5BNVkyazVyUUlEU25Bek1VNDdQX1M4MWU2S1NKaEF5VnAzTWFSNUk5R3Y2VjRENHplNzQwMEdPSExqSmZrOEtwOVFmSkNCbFh2WEtBZXQ0d1J1cVVubnRmUHU2dEhqc1Z6R2RnckdHZlByLTNiYUd1MWh3cmV3?oc=5">Yahoo Finance</source></item>
</channel></rss>